SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-22-117095
Filing Date
2022-11-10
Accepted
2022-11-10 16:00:54
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q atxs-20220930x10q.htm   iXBRL 10-Q 1595934
2 EXHIBIT-31.1 atxs-20220930xex31d1.htm EX-31.1 12521
3 EXHIBIT-31.2 atxs-20220930xex31d2.htm EX-31.2 12397
4 EXHIBIT-32.1 atxs-20220930xex32d1.htm EX-32.1 9594
  Complete submission text file 0001104659-22-117095.txt   6360030

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atxs-20220930.xsd EX-101.SCH 44225
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxs-20220930_cal.xml EX-101.CAL 46690
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20220930_def.xml EX-101.DEF 201402
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20220930_lab.xml EX-101.LAB 413412
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20220930_pre.xml EX-101.PRE 313707
59 EXTRACTED XBRL INSTANCE DOCUMENT atxs-20220930x10q_htm.xml XML 1076725
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 221376874
SIC: 2834 Pharmaceutical Preparations